Foresight Solar Fund Limited : Initial Placing and Offer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
98
Foresight Solar Fund Limited : Initial Placing and Offer Price

THIS ANNOUNCEMENT, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO U.S. PERSONS, OR IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

This announcement does not constitute an offer to sell, or the solicitation of an offer to subscribe for, or to buy shares in any jurisdiction.

This announcement is an advertisement and not a prospectus.  Any investment in any shares referred to in this announcement may be made only on the basis of information in the prospectus published by Foresight Solar Fund Limited on 3 March 2017, in connection with an initial placing, offer for subscription, private placement and a placing programme of ordinary shares of no par value each, to be admitted to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc.

14 March 2017

 

Foresight Solar Fund Limited (the "Company")

Initial Placing and Offer Price

 

On 3 March 2017, the Board of Foresight Solar Fund Limited (the "Company") announced its intention to raise in excess of £50 million by way of an Initial Placing and Offer for Subscription (the "Initial Placing and Offer") and a secondary listing ("Secondary Listing") on the main board of the securities exchange operated by the JSE Limited ("JSE") and Private Placement in South Africa (the "Private Placement") of new Ordinary Shares ("New Shares") (together the "Initial Issues"). The Company also announced its unaudited NAV as at 23 February 2017 of £360 million, resulting in a NAV per share of 105.6 pence (31 December 2016: 102.9 pence).

 

The Board announces that the Initial Placing and Offer price is being set at 107.75 pence per New Share. 

 

The New Shares will be entitled to receive the interim dividend of 1.55p per Ordinary Share in respect of the period from 1 October 2016 to 31 December 2016 which will be paid on 5 May 2017 provided the holders of the New Shares are on the Register on 7 April 2017.

 

The timetable for the Initial Issues remains unchanged as per below.

 

EXPECTED TIMETABLE
Event Date
Initial Placing and Offer  
Latest time and date for return of Forms of Proxy for the General Meeting 4.30 p.m. on 20 March 2017
General Meeting 4.30 p.m. on 22 March 2017
Results of General Meeting 22 March 2017
Latest time and date for receipt of Application Forms under the Offer 11 a.m. on 28 March 2017
Latest time and date for commitments under the Initial Placing 11 a.m. on 29 March 2017
Results of Initial Placing and  Offer announced  29 March 2017
Admission and dealings in New Shares on the Main Market of the LSE commence 8.00 a.m. on 31 March 2017
Crediting of CREST accounts in respect of the New Shares 31 March 2017
Share certificates in respect of New Shares despatched (if applicable) on or around 10 April 2017
Secondary Listing and Private Placement  
Latest time and date for commitments under the Private Placement  12 p.m. (SAST) on 29 March 2017
JSE Private Placement closes 12 p.m. (SAST) on 29 March 2017
JSE Private Placement Price announced 29 March 2017
Results of the Private Placement released on SENS in South Africa 29 March 2017
Notification of allotments 29 March 2017
Anticipated Secondary Listing Date and commencement of trading on the Main Board of the JSE 8.00 a.m. (SAST) on 3 April 2017
Accounts at CSDPs or brokers updated and accounts debited in respect of the Private Placement Shares at the commencement of trade 3 April 2017
The dates and times specified above and mentioned throughout this document are subject to change. All references to times in this document are to London times, unless otherwise stated. In particular, subject to those matters on which the Issues are conditional, the Board may, with the prior approval of Stifel Nicolaus Europe Limited, J.P. Morgan Securities plc (which carries on its UK investment banking activities as J.P. Morgan Cazenove) and Rand Merchant Bank (a division of FirstRand Bank Limited), bring forward or postpone the closing time and date for the Issues. In the event that such time and date is changed, the Company will notify investors who have applied for New Shares of changes to the timetable either by post, by electronic mail or by the publication of a notice through a Regulatory Information Service.

 

For further information, please contact:

Foresight Group

Louise Chesworth                            lchesworth@foresightgroup.eu                                +44 (0)20 3667 8100

 

Stifel Nicolaus Europe Limited (Sponsor and Joint UK Bookrunner)         +44 (0)20 7710 7600

Mark Bloomfield

Neil Winward

Tunga Chigovanyika

 

J.P. Morgan Cazenove (Joint UK Bookrunner)                                                     +44 (0)20 7742 4000

William Simmonds

Anne Ross

Oliver Kenyon

 

Rand Merchant Bank (South African Bookrunner)                                             +27 (0)11 282 8000

Irshaad Paruk                                                                                                   

Samuel Barton-Bridges

 

IMPORTANT NOTICE

 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or into any other jurisdiction where to do so might constitute a violation or breach of any applicable law.  The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or in any jurisdiction in which such offer or solicitation is unlawful (the "Excluded Territories"). The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the US Investment Company Act of 1940, as amended and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any US Person (within the meaning of Regulation S under the Securities Act). The securities referred to herein have not been registered under the applicable securities laws of any state, province or territory of the Excluded Territories and, subject to certain exceptions, may not be offered or sold into or within any of the Excluded Territories or to any national, resident or citizen of any of the Excluded Territories.

 

This announcement has been issued by and is the sole responsibility of the Company.  No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Stifel Nicolaus Europe Limited ("Stifel"), J.P. Morgan Securities plc, which carries on its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove") or Rand Merchant Bank, a division of FirstRand Bank Limited ("RMB") or by any of their respective affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed.

 

Stifel is authorised and regulated in the United Kingdom by the Financial Conduct Authority (the "FCA"). Stifel is acting as sponsor and joint UK bookrunner to the Company and is acting for no-one else in connection with the Issues, this announcement or any other matters referred to in this announcement, and will not regard any other person as its client in relation to the Issues or any other matters referred to in this announcement. Stifel will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Issues or any other matter referred to in this announcement.

 

J.P. Morgan Cazenove is authorised by the Prudential Regulatory Authority (the "PRA") and is regulated in the United Kingdom by the FCA and PRA. J.P. Morgan Cazenove is acting as joint UK bookrunner to the Company and is acting for no-one else in connection with the Issues, this announcement or any other matters referred to in this announcement, and will not regard any other person as its client in relation to the Issues or any other matters referred to in this announcement. J.P. Morgan Cazenove will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Issues or any other matter referred to in this announcement.

 

RMB is authorised and regulated by the Financial Services Board of South Africa. RMB is acting as JSE sponsor and South African bookrunner to the Company and is acting for no-one else in connection with the Issues, this announcement or any other matters referred to in this announcement, and will not regard any other person as its client in relation to the Issues or any other matters referred to in this announcement.  Apart from the responsibilities and liabilities, if any, which may be imposed on it by the Financial Services Board of South Africa or the regulatory regime established thereunder, RMB will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Issues or any other matter referred to in this announcement.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on Stifel and J.P. Morgan Cazenove under the Financial Services and Markets Act 2000 (as amended) or the regulatory regime established thereunder or under the regulatory regime of any jurisdiction where the exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Stifel nor J.P. Morgan Cazenove nor any of their respective affiliates accept any responsibility or liability whatsoever for, nor make any representation or warranty, express or implied, concerning the contents of this announcement, including its accuracy, completeness or verification, or for any other statement made or purported to be made by the Company, or on the Company's behalf, or by Stifel or J.P. Morgan Cazenove, or on behalf of Stifel or J.P. Morgan Cazenove in connection with the Company, the Issues or the New Shares and nothing in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or future. To the fullest extent permitted by law, each of the Stifel and J.P. Morgan Cazenove and their respective affiliates disclaim all and any duty, liability or responsibility whatsoever, whether direct or indirect and whether in contract, in tort, under statute or otherwise (save as referred to above), which it might otherwise have in respect of this announcement or any such statement.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 52

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 497

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 95

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 199

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 136

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 196

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 207

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 7

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Object Management Group Seeks Input on New SPECTRA-CSV Spec

Updated Category News Views 255

Object Management Group's Latest Initiative for Cybersecurity Standards In a significant move towards enhancing cybersecurity measures, Object Management Group (OMG) has announced the public release of the SPECTRA-CSV specification. This document is now open for comments from interested stakeholders, as part of OMG's ongoing mission to develop timely and effective...

Continue Reading
Dizal's Innovative Treatments in Hematology Show Promising Results

Updated Category News Views 172

Dizal's Innovations in Hematology Treatment At a recent medical meeting, Dizal, a biopharmaceutical company dedicated to developing groundbreaking therapies for cancer and immunological diseases, shared compelling new data from its hematology drug portfolio. Investors and healthcare providers alike took note of the latest findings on golidocitinib and birelentinib,...

Continue Reading
Transforming Workplace Wellness with Rejuvenation Stations

Updated Category News Views 116

Rejuvenation Stations Revolutionizing Workplace Wellness In today's fast-paced world, workplace stress has become a significant concern for many, especially among healthcare professionals. The innovative solution offered by Rejuvenation Stations provides a refreshing break to help individuals manage their stress effectively. These wellness pods and kiosks are specifically...

Continue Reading
Watercrest Richmond Welcomes The New Year with Celebration

Updated Category News Views 155

Watercrest Richmond Celebrates the New Year in Style The residents and associates of Watercrest Richmond Assisted Living and Memory Care welcomed the New Year with a joyful celebration. This event marked not only a new calendar year but also the vibrant community spirit that thrives at this senior living facility. A Memorable New Year's Celebration The New Year's...

Continue Reading
Pinnacle Fertility Welcomes Dr. Si Won Lee to Enhance Care

Updated Category News Views 261

Pinnacle Fertility Virginia Enhances Patient Care with New Physician Pinnacle Fertility Virginia is thrilled to announce a significant enhancement to its patient care team with the addition of Dr. Si Won Lee, an internationally trained reproductive endocrinologist. This new appointment marks a notable expansion for the clinic, which has long been recognized as a leader in...

Continue Reading